Parkinson's Disease Treatment Market Report

Global and China Parkinson's Disease Treatment Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 06, 2022
  • PAGES：197
  • REPORT CODE：GMM1349067
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Parkinson's Disease Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Sun Pharma (India)

    • Impax Laboratories (US)

    • Valeant Pharmaceuticals (Canada)

    • US WorldMeds (US)

    • AbbVie (US)

    • Acadia (US)

    • Wockhardt (India)

    • UCB (Belgium)

    • Cipla (India)

    • Teva (Israel)

    • Dr Reddy's (India)

    • Zydus Cadila (India)

    • Merck (US)

    • Boehringer Ingelheim (Germany)

    • Intas (India)

    • Novartis AG (Switzerland)

    • GSK (UK)

    • Lundbeck (Denmark)

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Levodopa/carbidopa

    • Dopamine Receptor Agonists

    • MAO-Inhibitors

    • COMT-inhibitors

    • Anticholinergics

    • Other Drugs

    Application:

    • Hospital Pharmacies

    • Retailer Pharmacies

    • Online Pharmacies

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Parkinson's Disease Treatment Industry Overview

      • 1.1.1 Parkinson's Disease Treatment Market Scope and Market Segments

      • 1.1.2 Parkinson's Disease Treatment Industry Characteristics

      • 1.1.3 Global and China Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Parkinson's Disease Treatment Production Value and Growth Rate (2017-2028)

    • 1.2 Global Parkinson's Disease Treatment Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Levodopa/carbidopa

      • 1.2.2 Dopamine Receptor Agonists

      • 1.2.3 MAO-Inhibitors

      • 1.2.4 COMT-inhibitors

      • 1.2.5 Anticholinergics

      • 1.2.6 Other Drugs

    • 1.3 Global Parkinson's Disease Treatment Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital Pharmacies

      • 1.3.2 Retailer Pharmacies

      • 1.3.3 Online Pharmacies

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Parkinson's Disease Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Parkinson's Disease Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Parkinson's Disease Treatment Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Parkinson's Disease Treatment Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Parkinson's Disease Treatment Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Parkinson's Disease Treatment Industry Porter's Five Forces Model Analysis

      • 2.2.3 Parkinson's Disease Treatment Industry PEST Analysis

    • 2.3 Parkinson's Disease Treatment Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Parkinson's Disease Treatment Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Parkinson's Disease Treatment Industry

    Chapter 3 Global and China Parkinson's Disease Treatment Market, by Manufacturer

    • 3.1 Global and China Parkinson's Disease Treatment Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Parkinson's Disease Treatment Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Parkinson's Disease Treatment Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Parkinson's Disease Treatment Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Parkinson's Disease Treatment Market Top 3 Players

    Chapter 4 Global and China Parkinson's Disease Treatment Market, by Type (2017-2028)

    • 4.1 Parkinson's Disease Treatment Market Trend, by Type

    • 4.2 Global Parkinson's Disease Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Parkinson's Disease Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Parkinson's Disease Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Parkinson's Disease Treatment Price Trend, by Type (2017-2028)

    • 4.3 China Parkinson's Disease Treatment Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Parkinson's Disease Treatment Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Parkinson's Disease Treatment Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Parkinson's Disease Treatment Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Parkinson's Disease Treatment Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Parkinson's Disease Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Parkinson's Disease Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Parkinson's Disease Treatment Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Parkinson's Disease Treatment Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Parkinson's Disease Treatment Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Parkinson's Disease Treatment Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Parkinson's Disease Treatment Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Parkinson's Disease Treatment Market Analysis

    • 7.1 North America Parkinson's Disease Treatment Market, by Type

    • 7.2 North America Parkinson's Disease Treatment Market, by Application

    • 7.3 North America Parkinson's Disease Treatment Market Analysis and Forecast, by Country

      • 7.3.1 United States Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Parkinson's Disease Treatment Market Analysis

    • 8.1 Europe Parkinson's Disease Treatment Market, by Type

    • 8.2 Europe Parkinson's Disease Treatment Market, by Application

    • 8.3 Europe Parkinson's Disease Treatment Market Analysis and Forecast, by Country

      • 8.3.1 Germany Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Parkinson's Disease Treatment Market Analysis

    • 9.1 APAC Parkinson's Disease Treatment Market, by Type

    • 9.2 APAC Parkinson's Disease Treatment Market, by Application

    • 9.3 APAC Parkinson's Disease Treatment Market Analysis and Forecast, by Country

      • 9.3.1 China Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Parkinson's Disease Treatment Market Analysis

    • 10.1 Latin America, Middle East and Africa Parkinson's Disease Treatment Market, by Type

    • 10.2 Latin America, Middle East and Africa Parkinson's Disease Treatment Market, by Application

    • 10.3 Latin America, Middle East and Africa Parkinson's Disease Treatment Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Parkinson's Disease Treatment Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Parkinson's Disease Treatment Company Profiles

      • 11.1 Sun Pharma (India)

        • 11.1.1 Sun Pharma (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Sun Pharma (India) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.1.3 Sun Pharma (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Impax Laboratories (US)

        • 11.2.1 Impax Laboratories (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Impax Laboratories (US) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.2.3 Impax Laboratories (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Valeant Pharmaceuticals (Canada)

        • 11.3.1 Valeant Pharmaceuticals (Canada) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.3.3 Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 US WorldMeds (US)

        • 11.4.1 US WorldMeds (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 US WorldMeds (US) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.4.3 US WorldMeds (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 AbbVie (US)

        • 11.5.1 AbbVie (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 AbbVie (US) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.5.3 AbbVie (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Acadia (US)

        • 11.6.1 Acadia (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Acadia (US) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.6.3 Acadia (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Wockhardt (India)

        • 11.7.1 Wockhardt (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Wockhardt (India) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.7.3 Wockhardt (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 UCB (Belgium)

        • 11.8.1 UCB (Belgium) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 UCB (Belgium) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.8.3 UCB (Belgium) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 Cipla (India)

        • 11.9.1 Cipla (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 Cipla (India) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.9.3 Cipla (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Teva (Israel)

        • 11.10.1 Teva (Israel) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Teva (Israel) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.10.3 Teva (Israel) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Dr Reddy's (India)

        • 11.11.1 Dr Reddy's (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Dr Reddy's (India) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.11.3 Dr Reddy's (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Zydus Cadila (India)

        • 11.12.1 Zydus Cadila (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Zydus Cadila (India) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.12.3 Zydus Cadila (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.13 Merck (US)

        • 11.13.1 Merck (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.13.2 Merck (US) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.13.3 Merck (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.14 Boehringer Ingelheim (Germany)

        • 11.14.1 Boehringer Ingelheim (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.14.2 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.14.3 Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.15 Intas (India)

        • 11.15.1 Intas (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.15.2 Intas (India) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.15.3 Intas (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.16 Novartis AG (Switzerland)

        • 11.16.1 Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.16.2 Novartis AG (Switzerland) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.16.3 Novartis AG (Switzerland) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.17 GSK (UK)

        • 11.17.1 GSK (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.17.2 GSK (UK) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.17.3 GSK (UK) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.18 Lundbeck (Denmark)

        • 11.18.1 Lundbeck (Denmark) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.18.2 Lundbeck (Denmark) Parkinson's Disease Treatment Product Profiles, Application and Specification

        • 11.18.3 Lundbeck (Denmark) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Parkinson's Disease Treatment Industry Investment Prospect and Risk Assessment

    • 12.1 Parkinson's Disease Treatment Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Parkinson's Disease Treatment Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Treatment Production Value and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Treatment Production Value and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of Levodopa/carbidopa (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of Dopamine Receptor Agonists (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of MAO-Inhibitors (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of COMT-inhibitors (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of Anticholinergics (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of Other Drugs (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of Hospital Pharmacies (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of Retailer Pharmacies (2017-2028)

    • Figure Global Parkinson's Disease Treatment Market Size and Growth Rate of Online Pharmacies (2017-2028)

    • Figure North America Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatment Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Parkinson's Disease Treatment Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Parkinson's Disease Treatment Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Parkinson's Disease Treatment Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Treatment Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Parkinson's Disease Treatment Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Parkinson's Disease Treatment Market Share, by Manufacturer in 2021

    • Figure Global and China Parkinson's Disease Treatment Market Share, by Manufacturer in 2022

    • Table Global Parkinson's Disease Treatment Sales Volume, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatment Sales Value, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatment Sales Value Share, by Type (2017-2028)

    • Figure Global Parkinson's Disease Treatment Price Trend, by Type (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Volume, by Type (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Value, by Type (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Value Share, by Type (2017-2028)

    • Figure China Parkinson's Disease Treatment Price Trend, by Type (2017-2028)

    • Table Global Parkinson's Disease Treatment Sales Volume, by Application (2017-2028)

    • Table Global Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Table Global Parkinson's Disease Treatment Sales Value, by Application (2017-2028)

    • Table Global Parkinson's Disease Treatment Sales Value Share, by Application (2017-2028)

    • Figure Global Parkinson's Disease Treatment Sales Value Share, by Application (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Volume, by Application (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Value, by Application (2017-2028)

    • Table China Parkinson's Disease Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatment Sales Value Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure North America Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatment Production, Import, Consumption and Export (2017-2022)

    • Table North America Parkinson's Disease Treatment Sales Volume, by Type (2017-2028)

    • Table North America Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Figure North America Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Table North America Parkinson's Disease Treatment Sales Volume, by Application (2017-2028)

    • Table North America Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure North America Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure United States Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure United States Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Table Europe Parkinson's Disease Treatment Sales Volume, by Type (2017-2028)

    • Table Europe Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Europe Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Table Europe Parkinson's Disease Treatment Sales Volume, by Application (2017-2028)

    • Table Europe Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Europe Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Germany Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure UK Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure France Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Table APAC Parkinson's Disease Treatment Sales Volume, by Type (2017-2028)

    • Table APAC Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Figure APAC Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Table APAC Parkinson's Disease Treatment Sales Volume, by Application (2017-2028)

    • Table APAC Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure APAC Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure China Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure China Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure India Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatment Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatment Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatment Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Parkinson's Disease Treatment Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Treatment Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Parkinson's Disease Treatment Sales Value and Growth Rate (2017-2028)

    • Table Sun Pharma (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sun Pharma (India) Product Profiles, Application and Specification

    • Table Sun Pharma (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Impax Laboratories (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Impax Laboratories (US) Product Profiles, Application and Specification

    • Table Impax Laboratories (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Valeant Pharmaceuticals (Canada) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Valeant Pharmaceuticals (Canada) Product Profiles, Application and Specification

    • Table Valeant Pharmaceuticals (Canada) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table US WorldMeds (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table US WorldMeds (US) Product Profiles, Application and Specification

    • Table US WorldMeds (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie (US) Product Profiles, Application and Specification

    • Table AbbVie (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Acadia (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Acadia (US) Product Profiles, Application and Specification

    • Table Acadia (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Wockhardt (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Wockhardt (India) Product Profiles, Application and Specification

    • Table Wockhardt (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table UCB (Belgium) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table UCB (Belgium) Product Profiles, Application and Specification

    • Table UCB (Belgium) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Cipla (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Cipla (India) Product Profiles, Application and Specification

    • Table Cipla (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Teva (Israel) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Teva (Israel) Product Profiles, Application and Specification

    • Table Teva (Israel) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Dr Reddy's (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Dr Reddy's (India) Product Profiles, Application and Specification

    • Table Dr Reddy's (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Zydus Cadila (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Zydus Cadila (India) Product Profiles, Application and Specification

    • Table Zydus Cadila (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Merck (US) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Merck (US) Product Profiles, Application and Specification

    • Table Merck (US) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Boehringer Ingelheim (Germany) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Boehringer Ingelheim (Germany) Product Profiles, Application and Specification

    • Table Boehringer Ingelheim (Germany) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Intas (India) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Intas (India) Product Profiles, Application and Specification

    • Table Intas (India) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Novartis AG (Switzerland) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Novartis AG (Switzerland) Product Profiles, Application and Specification

    • Table Novartis AG (Switzerland) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GSK (UK) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GSK (UK) Product Profiles, Application and Specification

    • Table GSK (UK) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Lundbeck (Denmark) Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Lundbeck (Denmark) Product Profiles, Application and Specification

    • Table Lundbeck (Denmark) Parkinson's Disease Treatment Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US